β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models-Reference-Cited by-同舟云学术

β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models

Published:2023-09 Issue: Volume:361 Page:636-658
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Israel Liron L.,Sun Tao,Braubach Oliver,Cox Alysia,Shatalova Ekaterina S.,Rashid Harun-Mohammad,Galstyan Anna,Grodzinski Zachary,Song Xue Ying,Chepurna Oksana,Ljubimov Vladimir A.,Chiechi Antonella,Sharma Sachin,Phebus Connor,Wang Yizhou,Ljubimova Julia Y.,Black Keith L.,Holler Eggehard

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference108 articles.

1. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma;Dréan;Expert. Rev. Neurother.,2016

2. Blood–brain barrier structure and function and the challenges for CNS drug delivery;Abbott;J. Inherit. Metab. Dis.,2013

3. Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model;Parrish;J. Pharmacol. Exp. Ther.,2015

4. Signature effects of vector-guided systemic nano bioconjugate delivery across blood-brain barrier of normal, Alzheimer’s, and tumor mouse models;Israel;ACS Nano,2022

5. https://www.alz.org/alzheimers-dementia/facts-figures, Alzheimer's Association - Facts and Figures, 2020.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target-Triggered Multiple-Polarity-Switchable Multiplexed Photoelectrochemical Platform;Analytical Chemistry;2024-08-28

2. Nanoparticles crossing blood–brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions;Nanomedicine;2024-08-07

3. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements;Ageing Research Reviews;2024-08

4. Surface Active Ligands for Enhanced Brain Targeting of Nanoparticles;Application of Nanocarriers in Brain Delivery of Therapeutics;2024